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ABSTRACT 
This study was designed to evaluate the effect of the oxidative stress in sera of young patients without a family history of 
hypertension, then find the relation of  it to lipid profile. The study involved 56 young healthy (30.5 ± 4.7 years) and 23 healthy 
elderly volunteers (66.3 ± 3.5 years), these individuals were compared with 67 patients (28.6 ± 5.0 years), attending the Gastro 
Intestinal and Liver Centre at Al Sader Medical City and several specialized clinics in Najaf government. Malondialdehyde level 
was measured by TBARS assay as reflection to the oxidative stress effect. Using standard enzymatic assays, TG, TC, HDL-C, 
VLDL- -C, and LDL-C values were measured for patientsand controls on the same day of sample obtainment. Levels of serum 
MDA, TG, VLDL-C, and LDL-C were significantly raised (p<0.005) in hypertensive patients group when compared with young 
and elderly controls, while non significant variations were obtained when the control groups were compared together. Daytime 
SBP and DBP were both strong positive correlated (r=0.82, p<0.005 for SBP, and r=0.95, p<0.005 for DBP) with the MDA in 
hypertensive patients, but in elderly controls only the correlation between SBP and MDA levels was statistically significant 
(r=0.61, p<0.005). Sera TG, VLDL-C, and LDL-C levels showed the same of MDA results when they were correlated to SBP and 
DBP, while correlations between blood pressure with sera TC were moderate positively in the study groups. In spite of; HDL-C 
levels in hypertensive patients were within the levels of those of two control groups, HDL-C levels showed negatively correlation 
with both SBP and DBP. Notably, there was a positive correlation (r=0.60, p<0.005) between serum LDL-C levels and SBP of 
elderly controls, no such correlations were observed when the relation was between Daytime SBP and DBP and VLDL-C or LDL-
C of young controls.the highly significant positive correlation (r = 0.94 at p<0.005) of MDA and TG of the hypertensive patients. 
Significant positive correlations were also observed for MDA with VLDL-C (r = 0.74 at p<0.005), and with LDL-C (r = 0.71 at 
p<0.005). It is well known that the endogenous female sex hormones have significant effect on lipid levels, according to that, 
testing the gender effect was occurred. MDA level in the study subgroups revealed a significant increase (p<0.005) in male 
patients when compared to females, while, student's t-test failed to exhibit significant changes among male and female subgroups 
in the control groups. Except for the significantly variation (p<0.005) of TG in the patient subgroups, all the other lipid profile 
parameters showed no significant differences between male and female subgroups. Concerning the controls’ subgroups, TG, TC, 
HDL-C, VLDL-C, and LDL-C were comparable between male and female subgroups. Finally, treatment for hypertension is 
similar for all demographic groups, but socioeconomic factors and lifestyle may be barriers to BP control in some patients, 
therefore; dealing with transitory hardships and arrangement of food style may be consider as a prim factors in the hypertension 
treatment.       
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1. INTRODUCTION 
Recent few years have witnessed an increasing the number of young hypertensive patients  (persistent and sustained 
high blood pressure) in the contrapuntal centres and clinics,  regardless their gender,  profession type, and dietary 
habits, but they have one subscriber peculiarity "they haven’t a family history of hypertension". For the aforesaid 
reason, the present study was designed, by measurement of malondialdehyde "MDA" level to assess lipid peroxidation 
in addition to lipid profiles levels. 
The pressure of blood flowing through the blood vessels against the vessel walls, it depend on the blood pumped from 
the heart and elasticity of the blood vessels. And varies with the age and human activity. Hypertension (a silent killer) 
is define as the blood pressure >140/90mmHg
1. hypertension is now a global epidemic affecting 1.5 billion people 
world wide and claiming about 7 million lives every year, and the number will increase to reach 1.56 billion in    
2025
2, 3. In Iraq, like many other countries in Arab Gulf region, where adoption of western lifestyles and the stress of 
urbanization both of which are expected to increase the morbidity associated with unhealthy and environmental factors 
are reported to play a key role in hypertension that major risk factor for cardiovascular events, such as myocardial 
infarction and stroke, as well as for microvascular complications, such as retinopathy and nephropathy
4. Hypertension 
problems become more dangerous in the young aged, where it may be decrease the medial people age. Hypertension is 
classified into two groups–primary or essential hypertension and secondary hypertension. Primary hypertension is 
defined as a ‘rise of blood pressure of unknown cause’. Secondary hypertension is the ‘increase in blood pressure 
caused by diseases of kidney, endocrines, or some other organs’. It is further graded into 3 stages based on the 
elevated blood pressures. Less than 5% of hypertensive patients develop malignant hypertension
5.  
O2 is both essential to human life and toxic 
6. Cellular, through a number of enzymatic and nonenzymatic processes, 
O2 accepts single electrons, it is transformed into highly reactive oxygen species (ROS), that damage cellular lipids, 
proteins, and DNA, that contributes to cellular death and degeneration in a wide range of diseases
6-8. ROSs can attack 
polyunsaturated fatty acids in cell membrane phospholipids, resulting in the formation of lipid peroxides which can Pakistan Journal of Chemistry 2011 
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then fragment to numerous small compounds, like MDA, 
9, 10, 8-isoprostane
11, 8-isoprostaglandins-F2α (8-iso-PGF)
12, 
and 8-hydroxy-2O-deoxyguanosine (8-OHdG)
13. Oxidative stress occurs when there is an imbalance between the 
generation of ROS and the antioxidant defence systems so that the latter become overwhelmed
11.  
The main aims of the present study are: evaluation of MDA levels as a reflection to the oxidative stress effect in sera 
of patients and healthy controls, then compared patient and healthy groups together, firstly, investigation whether 
serum  MDA  and  lipid  profile  are  harmoniously  changed  in  young  patients,  age-matched  and  elderly,  secondly;  
healthy individuals, and finally, sifting about the cause of the hypertension. 
 
2. EXPERIMENTAL 
 
2.1 Study Individuals 
Blood samples (approximately 5-10ml) were collected in appropriate sterile vials by venous arm after overnight 
fasting, through the present study that extended between July 2009 and September 2010. The study involved 56 young 
healthy (30 male and 26 female, mean age ± SD 30.5 ± 4.7 years) and 23 healthy elderly volunteers (11 male and 12 
female; mean age ± SD 66.3 ± 3.5). These individuals were compared with 67 patients (35 male and 32 female, 28.6 ± 
5.0 years), attending Gastro Intestinal and Liver Centre at Al Sader Medical City and several specialized clinics in 
Najaf  government.  The  majority  of  patients  studied  had  evidence  uncontrolled  hypertension  (the  definition  of 
hypertension was based on questionnaire information and blood pressure measurements; inclusion criteria included the 
patients with systolic blood pressure (SBP) ≥140 mm Hg and diastolic blood pressure (DBP) ≥90 mm Hg), pin-head, 
annoyance, and recur vomiting, but none had been hospitalized in the previous 6 months. In addition, the majority of 
patients were also receiving antihypertensive patients and antinational agents. Health was defined as an absence of 
major  medical  or  surgical  illness  in  the  previous5  years,  no  hospital  admissions,  no  current  medication,  and  a 
subjective perception of good health as determined by health questionnaire. None of the patients and control subjects 
had concomitant diseases such as diabetes mellitus, liver disease and rheumatoid arthritis. 
 
2.2 Measurement of Serum Malondialdehyde Level 
Malondialdehyde level is measured by the thiobarbituric acid-reacting substances (TBARS) assay
14. Abridgment,150 
µl of the serum sample was mixed with 1 ml of trichloro acetic acid (17.5 %) and 1ml of thiobarbituric acid (0.6 %). 
Using the vortex, the final mixture was mix, the reaction mixture was then heated at 100 °C for 15 minutes in a water 
bath. After the mixture was cooled with tap water, it was extracted with 1 ml TCA (70 %), the mixture was stand for 
20 minutes at 25 °C, and centrifuged at 3000 xg for 15 minutes. The organic phase was measured by use of a 
spectrophotometer with a wavelength of 534 nm. 
 
2.3 Measurement of Serum Lipid Profile Levels 
Using  standard  enzymatic  assays,  triglyceride  (TG),  total  cholesterol  (TC),  HDL-Cholesterol  (HDL-C),  VLDL-
Cholesterol (VLDL-C), and LDL-Cholesterol (LDL-C) values were measured for patients and controls on the same 
day of sample obtainment.  
 
2.4 Statistical Analysis 
The  findings  were  expressed  as  the  mean  ±  standard  deviation  (S.D.).The  data  were  analyzed  with  Student’s 
independent t test. All statistical analyses were performed with the program Statistical Package for the Social Science 
(SPSS for Windows, Version 10.0).Pearson’s correlation was applied to determined the relations among the blood 
pressure and the clinical and laboratory parameters of the present study, significance was determined regression. A p-
value of <0.005 was accepted as statistically significant. 
 
3. RESULTS AND DISCUSSION 
In the present study, the mean SBP of the three study groups was165±25, 110±10, and 120±15 for patients, young, 
and elderly individuals, respectively, while the mean DBP was 95±25, 70±10, and 85±5 for the contributor groups. 
Complete results of clinical and laboratory parameters are given in table 1. Serum MDA levels in hypertensive 
patients  were  significantly  higher  than  young  (p<0.005),  and  elderly  (p<0.005)  controls,  but  MDA  levels  were 
comparable between two control groups (p<0.01). Levels of TG, VLDL-C, and LDL-C were significantly raised 
(p<0.005) in hypertensive patients group when compared with young and elderly controls, while non significant 
variations  were  obtained  when  the  control  groups  were  compared  together.  On  the  other  hand,  non  significant 
variations were observed when the mean TC as well as HDL-C values of patients group was compared to those of 
young and elderly healthy individuals, with same manor; non statistical variation was noted when the two control 
groups where compared together.  
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Table-1: Levels (µM) of MAD and (mg/dL) of lipid profiles in patient and control subjects (mean ±  S.D.) 
Individual  MAD  TG  TC  HDL-C  VLDL-C  LDL-C 
P 
(67)  20.53±7.24  230±50  200±30  42.5±2  46.0±10  111.5±22 
Y 
(56)  9.69±2.63  120±30  170±20  47.0±8  24.0±6  99.1±13 
E 
(23)  13.52±3.33  140±35  175±35  43.2±6  34.0±11  97.8±14 
 
 
p-value 
<0.005 
for 
P vs Y 
<0.005 
for 
P vs E 
<0.01 
for 
Y vs E 
<0.005 for 
P vs Y 
<0.005 for 
P vs E 
<0.1 for 
Y vs E 
<0.01 for 
P vs Y 
<0.05 for 
P vs E 
<0.5 for 
Y vs E 
<0.5 for 
P vs Y 
<0.3 for 
P vs E 
<0.3 for 
Y vs E 
<0.005 for 
P vs Y 
<0.005 for 
P vs E 
<0.01 for 
Y vs E 
<0.005 for 
P vs Y 
<0.005 for 
P vs E 
<0.01 for 
Y vs E 
P: Patients, Y: Young Controls, E: Elderly Controls 
 
Daytime SBP and DBP were both strong positive correlated (r=0.82, p<0.005 for SBP, and r=0.95, p<0.005 for DBP) 
with the MDA in hypertensive patients, but in elderly controls only the correlation between SBP and MDA levels was 
statistically significant (r=0.61, p<0.005). Both SBP and DBP didn’t show statistical relation with sera MDA levels of 
young healthy individuals. Sera TG levels showed the same of MDA results when they were correlated to SBP and 
DBP, particularly, the results were so clear (r=0.91, p<0.005) when TG was correlated to the DBP in patients with the 
hypertension. Correlation between blood pressure (SBP and DBP) with sera TC were moderate positively in the study 
groups. In spite of; HDL-C levels in hypertensive patients were within the levels of those of two control groups, HDL-
C levels showed negatively correlation with both SBP and DBP, no such correlations were observed in the control 
groups. Daytime SBP and DBP were both positive correlated (r=0.67, p<0.005 for SBP, and r=0.78, p<0.005 for DBP, 
respectively) with VLDL-C levels, and (r=0.79, p<0.005 for SBP, and r=0.88, p<0.005 for DBP, respectively) with 
LDL-C levels in patients with hypertension. Notably, there was a positive correlation (r=0.60, p<0.005) between 
serum LDL-C levels and SBP of elderly controls, no such correlations were observed when the relation was between 
Daytime SBP and DBP and VLDL-C or LDL-C of young controls. The complete results are illustrated in Table-2.  
 
Table-2: Correlation of various study parameters to the dating blood pressure (SBP and DBP) in patients and controls 
Parameters 
Attachment to BP  P  p  Y  p  E  p 
SBP and MDA  0.82  <0.005  0.28  >0.5  0.61  <0.005 
SBP and TG  0.77  <0.005  0.09  >0.5  0.39  <0.01 
SBP and TC  0.69  <0.005  0.59  <0.005  0.62  <0.005 
SBP and HDL-C  -0.75  <0.005  -0.09  >0.5  0.22  >0.5 
SBP and VLDL-C  0.67  <0.005  0.25  <0.5  0.31  <0.5 
SBP and LDL-C  0.79  <0.005  0.30  <0.01  0.60  <0.005 
DBP and  MDA  0.95  <0.005  0.12  <0.05  0.35  <0.01 
DBP and TG  0.91  <0.005  0.11  >0.5  0.21  <0.5 
DBP and TC  0.73  <0.005  0.61  <0.005  0.63  <0.005 
DBP and HDL-C  -0.68  <0.005  -0.12  <0.5  -0.32  <0.5 
DBP and VLDL-C  0.78  <0.005  0.23  <0.5  0.30  <0.5 
DBP and LDL-C  0.88  <0.005  0.31  <0.05  0.40  <0.01 
P: Patients, Y: Young Controls, E: Elderly Controls 
 
According  to  the  study  outresults,  highlight  on  the  relation  between  MDA  and  the  lipid  profiles  that  appeared 
significantly variation than healthy controls was done,  for tracking the possible relationship. Thus,  the correlations 
were happened with TG, VLDL-C, and LDL-C, respectively. Figure 1. A illustrates the highly significant positive 
correlation (r = 0.94 at p<0.005) of MDA and TG of the hypertensive patients. Significant positive correlations were Pakistan Journal of Chemistry 2011 
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also observed for MDA with VLDL-C (r = 0.74 at p<0.005), and with LDL-C (r = 0.71 at p<0.005), (figure 1. B and 
C). 
 
Fig-1: Correlation of Serum Malondialdehyde and  (A): TG, (B):VLDL-C, and (C): LDL-C. 
 
It is well known that the endogenous female sex hormones have significant effect on lipid levels
51, thus it may effect 
on the present study parameters, according to that, testing the gender effect became so important. The evaluation of 
the MDA level in the study subgroups revealed a significant increase (p<0.005) in male patients when compared to 
females, while, student's t-test failed to exhibit significant changes among male and female subgroups in the control 
groups, as shown in table 3. Except for the significantly variation (p<0.005) of TG in the patient subgroups, all the 
other  lipid profile parameters showed no significant differences between male and female subgroups. Concerning the 
controls’ subgroups, TG, TC, HDL-C, VLDL-C, and LDL-C were comparable between male and female subgroups, 
data shown in table 3. 
 
Table-3: Levels (µM) of MAD and (mg/dL) of lipid profiles in male and female patient and control subjects (mean ± S.D.) 
Individual  MAD  TG  TC  HDL-C  VLDL-C  LDL-C 
P 
Male 
(35) 
Female 
(32) 
 
22.93±5.22 
 
17.42±8.55 
 
240±60 
 
190±35 
 
190±29 
 
205±35 
 
43.8±9 
 
42.0±2 
 
48.0±12 
 
38.0±7 
 
101.2±8 
 
125±26 
p-value  <0.005  <0.005  <0.01  <0.5  <0.05  <0.05 
Y 
Male 
(30) 
Female 
(26 ) 
 
9.88±1.2 
 
8.79±2.3 
 
122±20 
 
115±35 
 
167±10 
 
155±25 
 
35.1±3 
 
44.2±4 
 
24.4±4 
 
23.0±7 
 
87.5±3 
 
67.8±14 
p-value  <0.5  <0.5  <0.1  <0.05  <0.5  <0.05 
E 
Male 
(11) 
Female 
(12 ) 
 
14.00±2.12 
 
13.08±5.87 
 
150±40 
 
135±32 
 
190±17 
 
170±30 
 
38.5±2 
 
39.9±1 
 
35.0±1 
 
33.2±2 
 
113±14 
 
91.9±27 
p-value  <0.1  <0.05  <0.01  <0.5  <0.05  <0.01 
P: Patients, Y: Young Controls, E: Elderly Controls 
 
Hypertension is may due to the genetic predisposition, secondary life styles, fatty food consumption, saturated fat, 
cholesterol in the food increase the blood cholesterol and saturated fat is the main culprit, smoking and increased 
alcohol intake
16,  17. Generally; more than 80% of people with hypertension have additional comorbidities, such as 
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obesity, glucose intolerance, hyperinsulinemia, etc. More than 50% of people with hypertension have two or more 
comorbidities
5. The contributor patients in the present study were non smoking young individuals (<35 years), most of 
them were within normal body mass index or less, city population, with multifarious style of aliment, without a family 
history of hypertension. The present study is done to study the pattern of lipid peroxidation (MDA) and lipid profile in 
young hypertensive patients compared to the controls (young and elderly).  
 
Current work would specifically like to mention about serum MDA, it showed a progressive rise with age. The 
relationship between ages versus serum MDA was ascertained by correlation coefficient and was found out to be 0.68 
(p<0.005) which is highly significant. These observations were highly interesting.  
 
The SBP is increased as the age progresses in the different study cases and the highest levels was recorded in the 
hypertensive  patients,  while  the  DBP  in  hypertensive  patients  is  also  higher  than  the  controls.  The  DBP  is  not 
increased as the age increased, it is stabilized. These observations suggest that SBP is the best predictor in elderly than 
DBP. 
 
ROSs form as a natural by product of the normal metabolism of oxygen and have important roles in a number of 
biological processes, such as the killing of bacteria
18. During times of environmental stress ROS levels can increase 
dramatically which can result in significant damage to cell structures, especially in absence of anti-oxidant defences, 
such as the enzymes superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase or antioxidant 
vitamins A, C and E and polyphenol antioxidants
11. Cardiovascular system regulation is underlying several molecules, 
two of the most important compounds are angiotensin II (Ang II) and nitric oxide (NO), the central role of these 
molecules in the development of hypertension and hypertension-induced organ damage have been firmly established 
19. When the genetic effect excluded the hypertension may explain through the effect of oxidative stress. Oxidative 
stress may contribute to the generation and/or maintenance of hypertension via a number of possible mechanisms, 
included: (1) Quenching of the vasodilator NO by ROS such as superoxide. (2) Generation of vasoconstrictor lipid 
peroxidation products. (3) Depletion of tetra hydro biopterin (BH4), an important NO synthase cofactor.(4) Structural 
and functional alterations within the vasculature
20. These vascular changes may be mediated in several ways
7, 21, thus, 
oxidative stress promotes vascular smooth muscle cell proliferation and hypertrophy and collagen deposition, leading 
to thickening of the vascular media and narrowing of the vascular lumen. In addition, increased oxidative stress may 
damage the endothelium and impair endothelium-dependent vascular relaxation and increases vascular contractile 
activity. All these effects on the vasculature may explain how increased oxidative stress can cause hypertension
20, 22. 
The role of oxidative stress in the complex mechanisms involved in blood pressure control has been extensively 
analyzed
16, 23. Several clinical studies are pointing to the fact that therapies reduce blood pressure (manufactured or 
natural), possibly exhibit their effect via stimulation of the antioxidant systems
24, 25. 
 
In  the  present  study,  It  has  been  estimated  that  the  risk  of  hypercholesterolemia  is    higher  in  40%  of  healthy 
menopausal females, while no such observation was recorded in healthy young females or elderly males; on the other 
hand,  it has been observed that the risk of hypertriglyceridemia is  raised  in 17% of young healthy males, and in 37% 
of  elderly  healthy  males.  These  observations  agreed  with  several  studies
16,  17,  26.  Non  significant  variation  were 
observed when TC and HDL-C levels of hypertensive patients were compared to those of nontensive groups, these 
findings  disagree  with  most  of  hypertension  related  lipid  profile  studies
5,27,  thus;  these  results  prompted  to 
determination of  the TC/HDL-C ratio for the study  groups. According to the recommendations of Joint British 
Societies TC/HDL-C ratio should be below 4.5
28, in the present study this ration was within the normal level for both 
control groups (3.6 in young and 4.1 for elderly) , while patients group recorded high TC/HDL-C ratio (5.2), as table 1 
illustrated. 
 
Different serum lipids vary significantly in various population groups due to difference in geographical, cultural, 
economical, social conditions, dietary habits and genetic makeup
2. Age and gender differences also affect serum lipids 
considerably
29,30.  Elevated  levels  of  triglyceride,  cholesterol  and  LDLC  are  documented  as  risk  factors  for 
atherogenesis
2. LDL-C in its oxidized or acetylated form has been identified as a major atherogenic particle; as it not 
only  load  macrophages  with  cholesterol  for  the  formation  of  foam  cells  but  also  because  it  is  chemotactic  for 
circulating monocytes, iscytotoxic and can adversely alter coagulation pathways
31-33. The blood level of HDL-C in 
contrast bears an inverse relationship of the risk of atherosclerosis and coronary heart disease that is higher the level, 
smaller the risk
2. The association of alteration in serum lipid profile in hypertension is well documented in many 
various studies
8, 17. 
 
The  reason  behind  the  abnormal  lipid  metabolism  in  hypertension  may  be  the  genetic  locus  associated  with 
dyslipidemia accompanying hypertension
8.  Pakistan Journal of Chemistry 2011 
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According to the information in the Gunderson guides
23 in persons aged 40–70 years, each increment of 20 mmHg in 
SBP or 10 mmHg in DBP doubles the risk of CVD across the entire BP range from 115/75 to 185/115 mmHg, these 
pitfalls may increase as the person infected with the malignant hypertension in the young age, as the present study 
patients. Therefore, the current research indicates that the maintaining of the oxidative balance and monitoring of the 
lipid  level  in  hypertensive  patients  would  be  helpful  in  preventing  the  CVD  and  other  diseases  associated  with 
hypertension. Finally, treatment for hypertension is similar for all demographic groups, but socioeconomic factors and 
lifestyle  may  be  barriers  to  BP  control  in  some  patients
16,  34,  therefore;  dealing  with  transitory  hardships  and 
arrangement of food style may be consider as a prim factors in the hypertension treatment.       
 
4. REFERENCES 
 
1.  Turner J. IU Centerfor  Sport Medicine, (2002). 
2.  Abubakar A, Mabruok MA, Gerie AB, Dikko AA, Aliyu S, Yusuf T, Magaji RA, Kabir MA, and Adama 
UW. Asian Journal of Medical Sciences. (2009), 1(3): 94-96. 
3.  Maharjan  BR,  Jha  JC,  Vishwanath  P,  Alurkar  VM,  and  Singh  PP.J  Nepal  Health  Res  Counc.  (2008), 
6(13):63-68. 
4.  Arauz-Pacheco C, Parrott M, and Raskin P.Diabetes Care, (2002), 25(1):134-147. 
5.  Kumar N, Deepthi J, Rao Y, and Deedi M. Biology and Medicine, (2010) 2(1): 6-16. 
6.  Smith C, Marks A, and Lieberman M. 2
nd Edition. Lippincott Williama and Wilkins, (2009), pp439-457. 
7.  Lingyun W, Hossein A, Marina F, Phyllis P, Alison F, and Bernhard J.PNAS. (2004), 101(18): 7094–7099. 
8.  Sahu S, Abraham R, Vedavallir R, and Daniel M. Indian J PhysiolPharmacol. (2009), 53 (4): 365–369. 
9.  McGrath L, McGleenon B, Brennan S, McColl D, McIlroy S, and Passmore A. Q J Med. 2001, 94: 485-490. 
10. Guimarães S, Aragão A, Santos J, Kimura O, Barbosa P, and de Vasconcelos P. ActaCirúrgicaBrasileira. 
(2007), 22(1): 30-33. 
11. Ramón R, Hernán P, Walter P, Julia A, Cristián G), and Jean P. Hypertens Res. (2007), 30(12):1159–1167. 
12. Chen  C,  Arjomandi  M,  Balmes  J, Tager  I,  and  Holland  N.  Environmental  Health  Perspectives.  (2007), 
115(12): 1732–1737. 
13. Asakawa T, Yoshiaki Tanaka Y, Asagiri K, Kobayashi H, Tanikawa K, and Yagi M. PediatrSurg Int. (2009), 
25:93–97. 
14. Yagi K.Editor Lipid Peroxides in Biology and Medicine. New York. (1982) pp233–242. 
15. Aziz R and Mahboob T. Pak J Med Sci. (2007), 23(5): 751-754. 
16. Huang N. Australian  Prescriber. (2008), 31(6):150–153. 
17. Hang Y. American Journal of Transplantation. 9 (Supplemental 3) (2009), S71–S79. 
18. Hegde A, Bhat G, and Mallya S. Indian Journal of Medical Microbiology. (2008), 26(1): 25-28. 
19. Ungvari Z, Kaley G, de Cabo R, Sonntag W, and Csiszar A. J Gerontol A BiolSci Med Sci. (2010), 65A(10): 
1028 - 1041.  
20. Grossman E.Diabetes Care. 31 (Supplement 2), (2008):S185–S189. 
21. Moncia G, Guy B, Anna D, Renata C, Robert F, Giuseppe G, Guido G, Anthony H, Sverre K, Stephane L, 
Krzysztof N, Luis R, Andrzej, R, Roland S, Struijker J, and Alberto Z. Journal of Hypertension. (2007), 
25(6): 1105-1187. 
22. Sáez G and Redon J. Rev Bras Hipertens. (2003), 10(4): 239-249. 
23. Gunderson  Lutheran.  La  Crosse,  Wisconsin  (608)  775–8000  or  (800)  370–9718,  Glhealthplan.Org, 
(2009/2010). 
24. Devi A. The Scientific World Journal. (2009), 9:366-372. 
25. Suttei J. Publisher: CRC, ISBN: (2009), 084933392X.p: 231. 
26. Khan J, RehmanA , Ali Shah A, and Jielani A. J Ayub Med Coll Abbottabad. (2006), 18(1): 1-3. 
27. Tunon J, Martin L, BlanoColio M, Tarin N, and Egido J. Vascular Health Risk Management J. (2007), 3(4): 
521-526. 
28. Ohlsen S and Rogers D. The Pharmaceutical J. (2004), 272: 57-58. 
29. Bistritzer T, Rosenzweig L, Barr J, Mayer S, Lahat E, Faibel H, Schlesinger Z, and Aladjem M. Archives of 
Disease in Childhood. (1995), 73: 62-65.  
30. Mankuta D, Elami-Suzin M, Elhayani A,  andVinker S. Lipids in Health and Disease. (2010), 9(58):1-4. 
31. Nag S, Daniel G, Bullano M, Kamal-Bahl S, Sajjan S, and Alexander C. Journal of Managed Care Pharmacy. 
(2007), 13(8): 652-663. 
32. Parasassi T, De Spirito M, Mei G, Brunelli R, Greco G, Lenzi L, Maulucci G, Nicolai E, Papi M, Arcovito G, 
Tosatto S, and FulvioUrsini F.FASEB J. (2008), 22: 2350–2356. 
33. Forrester J. J. Am. Coll. Cardiol. (2010), 56: 637-640. 
34. Sayyed A, Patil J, Chavan V, Patil S, SujeetCharugulla S , Sontakke A,  and Kantak N. Al Ameen J Med. S c 
i. (2010), 3 (1):42-49. 